NASDAQ NMS - GLOBAL MARKET · LUCD
+0.24% · $0.0000 · Vol 357.9K
Live · updated 10:19:12 ET
Lucid Diagnostics Inc

Lucid Diagnostics Inc

Health Care
$0.6250
Card
Relationship Map

Follow $LUCD

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $LUCD by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
LUCD
Lucid Diagnostics Inc
Wed Oct 7 · last completed session · daily score · 15h old
Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

31/ 100
Veridion Score
Lower range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Wed Oct 7 · last completed session · daily score · 15h old
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is LUCD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading LUCD catalysts
About Lucid Diagnostics Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2021
Employees
82
Country
US

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.6100
Day high
$0.6501
Day low
$0.6034
Previous close
$0.6235
52W high
$1.47
-57.48% from high
52W low
$0.5933
4% of range
Market cap
$119.1M
EPS
$-0.3600
Beta
1.07
Shares out
190.9M
Volume
357.9K
0.26× rel vol
Avg volume
1.4M
VWAP
$0.6229
Price history computed in-house
1W
-1.54%
1M
-30.31%
3M
-37.50%
1Y
-48.77%
YTD
-42.66%
SMA 50 $0.8808 · below
SMA 200 $1.08 · below
52W position 4%

LUCD overview

Veridion Score
31
Registered · 2026-10-07
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around LUCD.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading LUCD Form 4 filings
Public disclosures

Congress activity in LUCD

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

LUCD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for LUCD in this window.
Lobbying spend

LUCD lobbying filings, year to date.

Registered lobbying filings matched to Lucid Diagnostics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for LUCD in this window.
Loading news for LUCD
Analyst ratings
Sovereign unlock shows live analyst consensus for LUCD.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.